Factors Associated with Adherence to Mdr-Tb Medication in Mukono District A Case Study of Mukono Hc Iv

Contents

ABSTRACT......................................................................................................................................................4

DECLARATION ..........................................................................................................................................5

APPROVAL .................................................................................................................................................6

DEDICATION..............................................................................................................................................7

ACKNOWLEDGEMENT ............................................................................................................................8

LIST OF ACRONYMS ................................................................................................................................9

CHAPTER 1 ...............................................................................................................................................10

1.0 INTRODUCTION...................................................................................................................................................10

1.1 BACKGROUND INFORMATION.............................................................................................................................10

1.2 PROBLEM STATEMENT........................................................................................................................................11

1.3 JUSTIFICATION OF STUDY...................................................................................................................................12

1.4.0 RESEARCH OBJECTIVES...................................................................................................................................12

1.4.1 Broad Objective .........................................................................................................................................12

1.4.2 Specific Objectives.................................................................................................................................13

1.5 RESEARCH QUESTIONS.......................................................................................................................................13

1.6 SCOPE OF THE STUDY.........................................................................................................................................13

1.6.1 Time Scope.................................................................................................................................................13

1.6.2 Content Scope ............................................................................................................................................14

1.6.3 Geographical Scope...................................................................................................................................14

1.7 CONCEPTUAL FRAMEWORK................................................................................................................................15

CHAPTER 2: LITERATURE REVIEW ....................................................................................................16

CHAPTER 3: METHODOLOGY ..............................................................................................................24

3.1 INTRODUCTIONS.................................................................................................................................................24

3.2 STUDY DESIGN...................................................................................................................................................24

3.3 STUDY POPULATION...........................................................................................................................................24

3.4 STUDY POPULATION...........................................................................................................................................24

3.5 SAMPLING METHODS. .........................................................................................................................................25

3.5.1 Inclusion criteria........................................................................................................................................25

3.5.2 Exclusion Criteria......................................................................................................................................26

3.6: SAMPLE SIZE DETERMINATION. .........................................................................................................................26

3.7. DATA COLLECTION METHODS............................................................................................................................27

3.8. QUALITY CONTROL. ..........................................................................................................................................27

3.9 DATA ANALYSIS AND PRESENTATIONS ...............................................................................................................27

3.10. ETHICAL CONSIDERATION. ..............................................................................................................................27

CHAPTER 4: STUDY RESULTS..............................................................................................................29

4.0 INTRODUCTION...................................................................................................................................................29

4.0.1 DEMOGRAPHIC INFORMATION.........................................................................................................................29

3

Figure 1: Gender................................................................................................................................................29

Figure 2: Age distribution ..................................................................................................................................30

Table 1: Age distribution ....................................................................................................................................30

Figure 3: Tribe....................................................................................................................................................31

Figure 4: Marital status......................................................................................................................................31

Table 2: Marital status........................................................................................................................................31

Figure 5: Level of education...............................................................................................................................32

Figure 6: Knowledge on adherence to MDR-TB treatment................................................................................32

4.0.2 LEVEL OF ADHERENCE ....................................................................................................................................33

Table 3: Days missed taking drugs...................................................................................................................33

Figure 7: Those whose treatments were observed ..............................................................................................33

Figure 8: Person who observed treatment..........................................................................................................33

Figure 9: Those who have ever missed their dose of MDR-TB drugs.................................................................34

Table 4: Those who have experienced side effects from drugs they are currently using and affected adherence

............................................................................................................................................................................35

Table 5: Distance from the health facility affecting adherence to medication ...................................................35

Table 6: Those who have received counselling concerning their treatment .......................................................35

Figure 10: Number of counselling sessions........................................................................................................36

Table 7: Those who have received any form of financial support ......................................................................36

CHAPTER 5: DISCUSSION, CONCLUSION AND RECOMMENDATION .........................................37

5.1: DISCUSSION OF FINDINGS ..................................................................................................................................37

5.2 CONCLUSION......................................................................................................................................................38

5.3 RECOMMENDATION............................................................................................................................................38

REFERENCES ...........................................................................................................................................40

APPENDICES ............................................................................................................................................42

APPENDIX 1: RESEARCH QUESTIONNAIRE SHEET......................................................................................42

APPENDIX 2: MAP OF MUKONO .......................................................................................................................47

APPENDIX 3: MAP OF UGANDA........................................................................................................................48